Effectiveness of a Bivalent, Killed Whole-cell Based Oral Cholera Vaccine (Shanchol) Delivered Through Community-based Mass Vaccination Campaign in a High-risk Population in India: Matched Case-control Studies.
Phase of Trial: Phase IV
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Cholera vaccine inactivated (Primary)
- Indications Cholera
- Focus Therapeutic Use
- 04 Jun 2013 Planned number of patients changed from 48 to 240 as reported by ClinicalTrials.gov.
- 04 Jun 2013 Planned End Date changed from 1 Jun 2014 to 1 Mar 2014 as reported by ClinicalTrials.gov.
- 01 Mar 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.